Home Newsfeeds Milestone Pharmaceuticals Q3 EPS $(0.34), Same YoY

Milestone Pharmaceuticals Q3 EPS $(0.34), Same YoY

Milestone Pharmaceuticals (NASDAQ:MIST) reported quarterly losses of $(0.34) per share. This is unchanged from the same period last year.

byBenzinga Newsdesk

November 10, 2022

1 minute read

Milestone Pharmaceuticals (NASDAQ:MIST) reported quarterly losses of $(0.34) per share. This is unchanged from the same period last year.

Investors Cheer Optical Cable’s Q4 Performance, Clocks Over 26% Revenue Growth And Margin Expansion

By Anusuya Lahiri

December 22, 12:51 PM

Optical Cable Corp (NASDAQ: OCC) reported fourth-quarter FY22 net sales growth of 26.3% year-on-year to $20.1 million.

OCC

TC BioPharm Announces Exercise Of Warrants For £3.1 Million Gross Proceeds

By Benzinga Newsdesk

May 6, 1:03 PM

TC BioPharm (Holdings) plc ("TC BioPharm" or the "Company") (NASDAQ:TCBP), a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer, today announced the entry into a

TCBP

Jim Cramer Backs Jensen Huang, Tim Cook Amid Wall Street Skepticism: ‘Don’t Scoff When I Tell You To Have Faith In These People’

By Benzinga Neuro

April 11, 11:08 PM

Cramer urged Wall Street to trust these influential figures, who he believes have consistently delivered positive results. He criticized the skeptics, stating, "It's the skeptics who've been wrong — the skeptics — year after year after darn year.

AAPL

Missfresh Regained Compliance with Nasdaq Periodic Filing Requirement –

By Charles Gross

November 16, 6:31 AM

Missfresh Limited (Nasdaq: MF) ("Missfresh" or the "Company"), an innovator in China's neighborhood retail industry, today announced that it received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") dated November 15, 2022 (the "Compliance Notification"), indicating that

Milestone Pharmaceuticals Q3 EPS $(0.34), Same YoY

Related Posts

Investors Cheer Optical Cable’s Q4 Performance, Clocks Over 26% Revenue Growth And Margin Expansion

TC BioPharm Announces Exercise Of Warrants For £3.1 Million Gross Proceeds

Jim Cramer Backs Jensen Huang, Tim Cook Amid Wall Street Skepticism: ‘Don’t Scoff When I Tell You To Have Faith In These People’

Missfresh Regained Compliance with Nasdaq Periodic Filing Requirement –